196 related articles for article (PubMed ID: 15983304)
1. Decreased lung function in female but not male subjects with established cystic fibrosis-related diabetes.
Sims EJ; Green MW; Mehta A
Diabetes Care; 2005 Jul; 28(7):1581-7. PubMed ID: 15983304
[TBL] [Abstract][Full Text] [Related]
2. Staphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes.
Limoli DH; Yang J; Khansaheb MK; Helfman B; Peng L; Stecenko AA; Goldberg JB
Eur J Clin Microbiol Infect Dis; 2016 Jun; 35(6):947-53. PubMed ID: 26993289
[TBL] [Abstract][Full Text] [Related]
3. Cystic-fibrosis related-diabetes (CFRD) is preceded by and associated with growth failure and deteriorating lung function.
Terliesner N; Vogel M; Steighardt A; Gausche R; Henn C; Hentschel J; Kapellen T; Klamt S; Gebhardt J; Kiess W; Prenzel F
J Pediatr Endocrinol Metab; 2017 Aug; 30(8):815-821. PubMed ID: 28245190
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of glucose intolerance in cystic fibrosis.
Mohan K; Miller H; Dyce P; Grainger R; Hughes R; Vora J; Ledson M; Walshaw M
Diabet Med; 2009 Jun; 26(6):582-8. PubMed ID: 19538232
[TBL] [Abstract][Full Text] [Related]
5. Increased rate of lung function decline in Australian adolescents with cystic fibrosis.
Welsh L; Robertson CF; Ranganathan SC
Pediatr Pulmonol; 2014 Sep; 49(9):873-7. PubMed ID: 24178906
[TBL] [Abstract][Full Text] [Related]
6. Cystic fibrosis-related diabetes in adults.
Cawood TJ; McKenna MJ; Gallagher CG; Smith D; Chung WY; Gibney J; O'Shea D
Ir Med J; 2006 Mar; 99(3):83-6. PubMed ID: 16700261
[TBL] [Abstract][Full Text] [Related]
7. Sex disparities in effects of cystic fibrosis-related diabetes on clinical outcomes: a matched study.
Miller RJ; Tildesley HD; Wilcox PG; Zhang H; Kreisman SH
Can Respir J; 2008 Sep; 15(6):291-4. PubMed ID: 18818782
[TBL] [Abstract][Full Text] [Related]
8. Elevation of 1-hour plasma glucose during oral glucose tolerance testing is associated with worse pulmonary function in cystic fibrosis.
Brodsky J; Dougherty S; Makani R; Rubenstein RC; Kelly A
Diabetes Care; 2011 Feb; 34(2):292-5. PubMed ID: 21228248
[TBL] [Abstract][Full Text] [Related]
9. Lumacaftor/ivacaftor therapy is associated with reduced hepatic steatosis in cystic fibrosis patients.
Kutney K; Donnola SB; Flask CA; Gubitosi-Klug R; O'Riordan M; McBennett K; Sferra TJ; Kaminski B
World J Hepatol; 2019 Dec; 11(12):761-772. PubMed ID: 31966908
[TBL] [Abstract][Full Text] [Related]
10. Diabetes is associated with dramatically decreased survival in female but not male subjects with cystic fibrosis.
Milla CE; Billings J; Moran A
Diabetes Care; 2005 Sep; 28(9):2141-4. PubMed ID: 16123480
[TBL] [Abstract][Full Text] [Related]
11. Importance of screening with oral glucose tolerance test for early diagnosis of cystic fibrosis-related diabetes mellitus.
Noronha RM; Damaceno N; Muramatu LH; Monte O; Calliari LE
Pediatr Diabetes; 2014 Jun; 15(4):309-12. PubMed ID: 24256553
[TBL] [Abstract][Full Text] [Related]
12. Glucose tolerance affects pubertal growth and final height of children with cystic fibrosis.
Bizzarri C; Montemitro E; Pedicelli S; Ciccone S; Majo F; Cappa M; Lucidi V
Pediatr Pulmonol; 2015 Feb; 50(2):144-9. PubMed ID: 24678051
[TBL] [Abstract][Full Text] [Related]
13. Association of the relative change in weight and body mass index with lung function in teenagers and adults with cystic fibrosis: Influence of gender and diabetes.
Cano Megías M; Guisado Vasco P; González Albarrán O; Lamas Ferreiro A; Máiz Carro L
Endocrinol Nutr; 2015 Nov; 62(9):422-9. PubMed ID: 26311609
[TBL] [Abstract][Full Text] [Related]
14. Hyperglycemia impedes lung bacterial clearance in a murine model of cystic fibrosis-related diabetes.
Hunt WR; Zughaier SM; Guentert DE; Shenep MA; Koval M; McCarty NA; Hansen JM
Am J Physiol Lung Cell Mol Physiol; 2014 Jan; 306(1):L43-9. PubMed ID: 24097557
[TBL] [Abstract][Full Text] [Related]
15. Cystic fibrosis related diabetes in Europe: Prevalence, risk factors and outcome; Olesen et al.
Olesen HV; Drevinek P; Gulmans VA; Hatziagorou E; Jung A; Mei-Zahav M; Stojnic N; Thomas M; Zolin A;
J Cyst Fibros; 2020 Mar; 19(2):321-327. PubMed ID: 31680042
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal relationship between physical activity and lung health in patients with cystic fibrosis.
Schneiderman JE; Wilkes DL; Atenafu EG; Nguyen T; Wells GD; Alarie N; Tullis E; Lands LC; Coates AL; Corey M; Ratjen F
Eur Respir J; 2014 Mar; 43(3):817-23. PubMed ID: 24176992
[TBL] [Abstract][Full Text] [Related]
17. Infection with transmissible strains of Pseudomonas aeruginosa and clinical outcomes in adults with cystic fibrosis.
Aaron SD; Vandemheen KL; Ramotar K; Giesbrecht-Lewis T; Tullis E; Freitag A; Paterson N; Jackson M; Lougheed MD; Dowson C; Kumar V; Ferris W; Chan F; Doucette S; Fergusson D
JAMA; 2010 Nov; 304(19):2145-53. PubMed ID: 21081727
[TBL] [Abstract][Full Text] [Related]
18. Microvascular complications in cystic fibrosis-related diabetes.
Schwarzenberg SJ; Thomas W; Olsen TW; Grover T; Walk D; Milla C; Moran A
Diabetes Care; 2007 May; 30(5):1056-61. PubMed ID: 17322485
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry.
Kerem E; Viviani L; Zolin A; MacNeill S; Hatziagorou E; Ellemunter H; Drevinek P; Gulmans V; Krivec U; Olesen H;
Eur Respir J; 2014 Jan; 43(1):125-33. PubMed ID: 23598952
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance, β-cell dysfunction and differences in curves of plasma glucose and insulin in the intermediate points of the standard glucose tolerance test in adults with cystic fibrosis.
Cano Megías M; González Albarrán O; Guisado Vasco P; Lamas Ferreiro A; Máiz Carro L
Endocrinol Nutr; 2015 Feb; 62(2):91-9. PubMed ID: 25444978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
